Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cultivating. Innovating. Operating: Discovering the Science of CBD

Dave Jackson Dave Jackson, Stockhouse
0 Comments| May 14, 2020

{{labelSign}}  Favorites
{{errorMessage}}

Sire Bioscience Inc’s (CSE.SIRE, OTC: BLLXF, Forum) business model is based on their ability to engage in the investment, production, and sale of hemp for CBD extraction. That’s the desirable scalable endgame for any cannabis company.

Sire is not in the THC business. The Company is in the health & wellness component of the space.

Sire says their goal is to become a fully vertically-integrated consumer packaged goods life science company with their House of Brands offerings. The Company is headquartered in Toronto Ontario and is backed by a group of successful entrepreneurs who have extensive experience in the areas of manufacturing, logistics, and renewable energy.

In this engaging and entertaining podcast, Stockhouse Media's Dave Jackson was joined by company CEO and COO, Brian Polla, to discuss new company developments, especially in the wake of the COVID-19, how Sire plans to become a disrupter in what Merrill-Lynch predicts to be a “$2.6 trillion CBD space”, and what being a brand-focused CBD / hemp and nutraceuticals company is all about.



Listen on Apple PodcastsListen on Google Podcasts


FULL DISCLOSURE: This is a paid article of Stockhouse Publishing.


{{labelSign}}  Favorites
{{errorMessage}}

Comments

No comments yet. Be first to comment!

Leave a Comment

You must be logged in to be able to post a comment.

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today